explore -WSS

explore

author：leisure time 2025-08-31 20:59:58 - browse：54

Stock illustration of computer and medication — Adobe

Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ most significant digital treatments will find a new life as part of PursueCare, which provides online addiction care and mental health counseling.

PursueCare today announced it had raised a $20 million Series B round and that it had acquired Pear’s portfolio of apps that treat people with addiction problems. PursueCare’s CEO Nick Mercadante told STAT the company hopes to develop the market for the treatments where Pear could not, by taking advantage of its access to patients and insurers.

“My view of digital therapeutics is that those point solutions really need a horse to draw the carriage,” he said. “You need a willing and capable service provider that says we’re going to make this a big part of real world care and… then show the health plans how it can save them money in the real world without extra thinking.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Merck drug for rare lung condition set for approval in U.S.

WSS

A strong 6.5

Flagship, Pfizer team up in deal worth up to $7 billion

Biden administration sends mixed signals on US soldier who crossed into North Korea

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

FDA seeking to stop procedures at two unregulated stem cell clinics

knowledge

explore

explore

What does generative AI mean for health care? We asked experts

FDA's naming rule on biosimilars has undermined competition

Medical records are filled with copy

Study: Hearing aids may slow cognitive decline in those at risk

Medicare details structure of new drug price negotiation program

Flagship, Pfizer team up in deal worth up to $7 billion

ChatGPT in medicine: STAT answers readers' burning questions

States should stop sabotaging methadone treatment reform

Medicare details structure of new drug price negotiation program

Why the world’s most expensive drug might be worth the price

knowledge

Study says nonprofit hospitals fall short in charity care spending

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

BridgeBio heart drug succeeds in pivotal study

Flagship, Pfizer team up in deal worth up to $7 billion

Donor acceptance rates hint at racial, gender bias in heart transplants: study

FDA seeking to stop procedures at two unregulated stem cell clinics

hotspot

hotspot

explore

hotspot